Literature DB >> 33922479

RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems.

Myeongwoo Jung1,2, Eun Kyung Lee1,3.   

Abstract

HuD (also known as ELAVL4) is an RNA-binding protein belonging to the human antigen (Hu) family that regulates stability, translation, splicing, and adenylation of target mRNAs. Unlike ubiquitously distributed HuR, HuD is only expressed in certain types of tissues, mainly in neuronal systems. Numerous studies have shown that HuD plays essential roles in neuronal development, differentiation, neurogenesis, dendritic maturation, neural plasticity, and synaptic transmission by regulating the metabolism of target mRNAs. However, growing evidence suggests that HuD also functions as a pivotal regulator of gene expression in non-neuronal systems and its malfunction is implicated in disease pathogenesis. Comprehensive knowledge of HuD expression, abundance, molecular targets, and regulatory mechanisms will broaden our understanding of its role as a versatile regulator of gene expression, thus enabling novel treatments for diseases with aberrant HuD expression. This review focuses on recent advances investigating the emerging role of HuD, its molecular mechanisms of target gene regulation, and its disease relevance in both neuronal and non-neuronal systems.

Entities:  

Keywords:  HuD; RNA–binding protein; disease pathology; neuronal systems; non–neuronal systems

Year:  2021        PMID: 33922479     DOI: 10.3390/biology10050361

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  117 in total

1.  HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.

Authors:  A Szabo; J Dalmau; G Manley; M Rosenfeld; E Wong; J Henson; J B Posner; H M Furneaux
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype.

Authors:  P H King
Journal:  Int J Cancer       Date:  1997-08-22       Impact factor: 7.396

3.  Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture.

Authors:  Chol Seung Lim; Daniel L Alkon
Journal:  Hippocampus       Date:  2012-06-27       Impact factor: 3.899

Review 4.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

Review 5.  RNA-binding proteins in human genetic disease.

Authors:  Fátima Gebauer; Thomas Schwarzl; Juan Valcárcel; Matthias W Hentze
Journal:  Nat Rev Genet       Date:  2020-11-24       Impact factor: 53.242

6.  Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.

Authors:  N S Ball; P H King
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

7.  Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA.

Authors:  Hui Zhu; Melissa N Hinman; Robert A Hasman; Priyesh Mehta; Hua Lou
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

8.  Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis.

Authors:  Riccardo De Santis; Vincenzo Alfano; Valeria de Turris; Alessio Colantoni; Laura Santini; Maria Giovanna Garone; Giuseppe Antonacci; Giovanna Peruzzi; Emma Sudria-Lopez; Emanuel Wyler; Jasper J Anink; Eleonora Aronica; Markus Landthaler; R Jeroen Pasterkamp; Irene Bozzoni; Alessandro Rosa
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

9.  Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer.

Authors:  Vito D'Alessandro; Lucia Anna Muscarella; Massimiliano Copetti; Leopoldo Zelante; Massimo Carella; Gianluigi Vendemiale
Journal:  Cell Oncol       Date:  2008       Impact factor: 6.730

10.  Translational derepression of Elavl4 isoforms at their alternative 5' UTRs determines neuronal development.

Authors:  Tatiana Popovitchenko; Yongkyu Park; Nicholas F Page; Xiaobing Luo; Zeljka Krsnik; Yuan Liu; Iva Salamon; Jessica D Stephenson; Matthew L Kraushar; Nicole L Volk; Sejal M Patel; H R Sagara Wijeratne; Diana Li; Kandarp S Suthar; Aaron Wach; Miao Sun; Sebastian J Arnold; Wado Akamatsu; Hideyuki Okano; Luc Paillard; Huaye Zhang; Steven Buyske; Ivica Kostovic; Silvia De Rubeis; Ronald P Hart; Mladen-Roko Rasin
Journal:  Nat Commun       Date:  2020-04-03       Impact factor: 14.919

View more
  7 in total

1.  Pum2 and TDP-43 refine area-specific cytoarchitecture post-mitotically and modulate translation of Sox5, Bcl11b, and Rorb mRNAs in developing mouse neocortex.

Authors:  Melanie Richter; Nagammal Neelagandan; Kawssar Harb; Elia Magrinelli; Hend Harfoush; Katrin Kuechler; Melad Henis; Irm Hermanns-Borgmeyer; Froylan Calderon de Anda; Kent Duncan
Journal:  Elife       Date:  2022-03-09       Impact factor: 8.140

2.  Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a.

Authors:  Shu-Qun Shi; Carrie E Mahoney; Pavel Houdek; Wenling Zhao; Matthew P Anderson; Xinming Zhuo; Arthur Beaudet; Alena Sumova; Thomas E Scammell; Carl Hirschie Johnson
Journal:  Front Behav Neurosci       Date:  2022-03-23       Impact factor: 3.558

3.  Loss of RNA binding protein HuD facilitates the production of the senescence-associated secretory phenotype.

Authors:  Seungyeon Ryu; Myeongwoo Jung; Chongtae Kim; Hoin Kang; Sukyoung Han; Seongho Cha; Seung Min Jeong; Eun Kyung Lee
Journal:  Cell Death Dis       Date:  2022-04-11       Impact factor: 8.469

4.  Study on the pro-inflammatory mechanism of the HuD antibody in promoting M1 polarization and paraneoplastic neurological syndrome occurrence.

Authors:  Liang Yin; Wen-Ling Yuan; Ke Wu; Li-Na Zhang; Qian-Qian Li
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.

Authors:  Yolanda Martín-Martín; Ana Pérez-García; Marta Torrecilla-Parra; Mario Fernández-de Frutos; Virginia Pardo-Marqués; María José Casarejos; Rebeca Busto; Cristina M Ramírez
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

6.  Combining affinity purification and mass spectrometry to define the network of the nuclear proteins interacting with the N-terminal region of FMRP.

Authors:  Félicie Kieffer; Fahd Hilal; Anne-Sophie Gay; Delphine Debayle; Marie Pronot; Gwénola Poupon; Iliona Lacagne; Barbara Bardoni; Stéphane Martin; Carole Gwizdek
Journal:  Front Mol Biosci       Date:  2022-09-27

7.  ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.

Authors:  Kathryn R Bowles; M Catarina Silva; Kristen Whitney; Taylor Bertucci; Joshua E Berlind; Jesse D Lai; Jacob C Garza; Nathan C Boles; Sidhartha Mahali; Kevin H Strang; Jacob A Marsh; Cynthia Chen; Derian A Pugh; Yiyuan Liu; Ronald E Gordon; Susan K Goderie; Rebecca Chowdhury; Steven Lotz; Keith Lane; John F Crary; Stephen J Haggarty; Celeste M Karch; Justin K Ichida; Alison M Goate; Sally Temple
Journal:  Cell       Date:  2021-07-26       Impact factor: 66.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.